Hodgkin's Disease: Related Videos
Fighting non-Hodgkin's lymphoma (NHL) can be a tough battle. Eileen Merle-Rao is a person with NHL who tried two different rounds of therapies, which ultimately failed her. Then her doctors suggested a unique form of radiation therapy called radioimmunotherapy. The best news is that Eileen has seen a marked improvement in her disease and now is looking forward to a future filled with possibility.
Keywords: Non-Hodgkin's Lymphoma, NHL, Lymphoma, Hodgkin's disease, Hodgkin's disease, cancer, tumor, radioimmunotherapy, targeted therapy, chemotherapy, immune system, antibodies, monoclonal antibodies, radioactive antibodies, radiation, cold antibody, unlabeled antibody, hot antibody, labeled antibody, radiolabeled antibody, complete remission, partial remission, partial response, complete response, unlabeled monoclonal antibody therapy, labeled monoclonal antibody therapy, low blood counts, myleosuppresion, neuropathy, antibody targeted treatments, cancer treatment, Zevalin, Ibritumomab, Bexxar, Tositumomab
Whether relapsed or refractory, tune in to learn about treatments for indolent non-Hodgkin's lymphoma.
Keywords: Radioimmunotherapy, non-Hodgkin's lymphoma, relapse, Indolent lymphoma, follicular lymphoma, Bexxar, Zevalin, remission, fludarabine, CHOP or CVP, monoclonal antibody,tumor, toxicity, long-term side effects
Non-Hodgkin's lymphoma is the sixth most frequent cancer. It affects the cells of the immune system that should be protecting the body against disease. Listen to experts discuss the ABCs of NHL.
Keywords: Lymphoma, Non-Hodgkin's lymphoma, NHL, Hodgkin's lymphoma, immune system, tumor, lymph nodes, spleen, bone marrow, lymph glands, glands, indolent lymphoma, aggressive lymphoma, slow-growing lymphoma, chemotherapy, radiation treatments, radiation, radiotherapy, immune therapy, immunotherapy, radioactive antibody, antibody, active immune therapy, passive immune therapy, passive immunotherapy, active immunotherapy, Hodgkins
Vaccines for cancer are no longer futuristic medicine. See how people with non-Hodgkin's lymphoma are on the cutting edge of research.
Keywords: Cancer, lymph glands, lymphoma, non-Hodgkin's lymphoma, NHL, antibody, antibodies, slow-growing NHL, low-grade lymphoma, high grade lymphoma, indolent NHL, aggressive NHL, follicular NHL, follicular non-Hodgkin's lymphoma, immunotherapy, customized immunotherapy, passive immunotherapy, active immunotherapy, B cell lymphoma, T cell lymphomas, immune system, tumor, biopsy, idiotype, vaccine, chemotherapy, radiation therapy, Rituxan, Rituximab fludara, fludarabine, Herceptin, trastuzumab, Zevalin, Ibritumomab, Tiuxetan, Bexxar, Tositumomab, Phase I trials, Phase II trials, Phase III trials, bone marrow biopsy, CT scans, Genitope, National Cancer Institute
Radiation can destroy cancer cells. People with cancers such as non-Hodgkin's lymphoma, now have new options that deliver this form of therapy in a very targeted way. A new treatment called radioimmunotherapy can deliver this radiation via medications, thereby targeting tumor cells wherever they are in the body. Learn about these novel medications and how they are being used today.
Keywords: Non-Hodgkins Lymphoma, Hodgkin's Lymphoma, NHL, radiation therapy, radiation, antibodies, monoclonal antibodies, isotopes, Iodine-131, Yttrium-90, beta radiation, gamma radiation, radioimmunotherapy, external beam radiation, conventional beam radiation, tumor, radioactive particles, antibody targeted therapy, Zevalin, Bexxar, Rituxan, rituximab, ibritumomab, tositumomab, myelosuppression, platelet count, white blood count, crossfire effect, nuclear medicine
Non-Hodgkin's lymphoma is a complex -- and often confusing -- group of diseases. Tune in for an expert overview of the biology of NHL, as well as its diagnosis and treatment.
Keywords: nhl, Lymphoma
Since non-Hodgkin's Lymphoma can appear in many places in the body, it's often difficult to direct treatment to the specific cancer cells without causing harm to healthy tissue. Now doctors can deliver a lethal punch against NHL with a therapy that targets the cancer cells with radiation attached to antibodies that specifically seek out the cancer cells. Learn how this new weapon against NHL may help people with this disease.
Keywords: Non-Hodgkin's Lymphoma, NHL, Lymphoma, Hodgkin's disease, Hodgkin's disease, cancer, tumor, radioimmunotherapy, targeted therapy, chemotherapy, immune system, antibodies, monoclonal antibodies, radioactive antibodies, radiation, cold antibody, unlabeled antibody, hot antibody, labeled antibody, radiolabeled antibody, complete remission, partial remission, partial response, complete response, unlabeled monoclonal antibody therapy, labeled monoclonal antibody therapy, low blood counts, myleosuppresion, neuropathy, antibody targeted treatments, cancer treatment, Zevalin, Ibritumomab, Bexxar, Tositumomab
Every year, the Lymphoma Research Foundation hosts a forum for people living with lymphoma and the healthcare professionals that care for them. People attending this weekend gathering exchange latest news about treatment and discuss issues important to people living with lymphoma. See highlights from featured speakers in excerpts from the 2002 Lymphoma Forum.
Keywords: lymphoma, non-Hodgkin's lymphoma, NHL, follicular lymphoma, cancer vaccine, BCL-2 antisense oligonucleotide, rituxan, rituximab, CHOP, B cell lymphoma, radioimmunotherapy, antibody, radiation, CLL, Hodgkin's disease, bone marrow transplantation, Bexxar, Zevalin
Targeted therapies, those that hone in on cancer cells, are the latest weapons used in the treatment of non-Hodgkin's lymphoma. Learn about the different targeted therapies available and how they are selected.
Keywords: targeted therapies, non-Hodgkin's lymphoma, NHL, lymphoma, cancer, Rituxan, rituximab, chemotherapy, radioimmunotherapy, radiation therapy, monoclonal antibodies, MAB's, Zevalin, Bexxar, ibritumomab, tositumomab, I-131, yttrium, bone marrow transplantation, stem cell transplant, cancer side effects, targeted therapy
Monoclonal antibodies are improving treatment success for many people with aggressive forms of non-Hodgkin's lymphoma. How do they work?
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkin's lymphoma, non Hodgkin's lymphoma, non-Hodgkin's lymphoma, indolent lymphoma, CD20, anti CD20, b-cell lymphoma, diffuse, large B-cell lymphoma
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.
Keywords: Cancer, lymph glands, lymphoma, non-Hodgkin's lymphoma, NHL, antibody, antibodies, slow-growing NHL, low-grade lymphoma, high-grade lymphoma, indolent NHL, aggressive NHL, follicular NHL, follicular non-Hodgkin's lymphoma, immunotherapy, customized immunotherapy, passive immunotherapy, active immunotherapy, B-cell lymphoma, T-cell lymphomas, immune system, tumor, biopsy, idiotype, vaccine, chemotherapy, Rituxan, Rituximab, fludara, fludarabine, Herceptin, trastuzumab, Zevalin, Ibritumomab, iuxetan, Bexxar, Tositumomab, cancer vaccine
Doctors are using drugs that mimic the natural immune response to help fight non-Hodgkin's lymphoma. Learn how these new treatments work.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkins lymphoma, non Hodgkin's lymphoma,
Targeted therapies are not just for advanced cases non Hodgkin's lymphoma. Learn how they can help against indolent or low-grade cancers as well.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkins lymphoma, non Hodgkin's lymphoma,
Learn how patients with indolent or slow-growing non-Hodgkin's lymphoma should go about picking the best treatment for themselves.
Keywords: A discussion of deciding among lymphoma treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma
In recent years, the drug Rituxan has become a well-established option only for certain forms of non-Hodgkin's lymphoma (NHL) There are other types of NHL where Rituxan may be beneficial, but its effects on these cancers are not well known. Join us as we talk to experts about some exciting research in this area which was discussed at the 2001 American Society of Hematology meeting.
Keywords: Rituxan, rituximab, monoclonal antibody, targeted therapy, B-cell, B lymphocyte, cancer, autoimmune, blood disorder, anemia, hemophilia, ITP, TTP, immune thrombocytopenic purpura, thrombotic thrombocytopenic purpura, NHL, non-Hodgkin's lymphoma, B-cell autoimmune disorders, acquired hemolytic anemia, factor VIII
Doctors are finding that monoclonal antibodies can be helpful in the treatment of recurrent, indolent non-Hodgkin's lymphoma.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non Hodgkin's lymphoma, indolent lymphoma, CD20, anti CD20, b-cell lymphoma
Learn about new treatments available for patients with relapsed, indolent non-Hodgkin's lymphoma, as well as potential future treatments.
Keywords: Radioimmunotherapy, non-Hodgkin's lymphoma, relapse, Indolent lymphoma, follicular lymphoma, Bexxar, Zevalin, remission, fludarabine, monoclonal antibody, tumor, toxicity, stem cell transplant, cytokines, rituxan, epratuzumab
One of the newest treatments for non-Hodgkin's lymphoma is radioimmunotherapy, a clever mixture of old and new that better targets cancer cells.
Keywords: radioimmunotherapy, non-Hodgkin's, lymphoma, NHL, cancer, cells, monoclonal antibodies, immune system, radioactive, protein, CD20 antigen, B-cells, lymphocytes, radiation therapy, tumor, localized, targeted therapy, radiation, Zevalin, Bexxar, rituximab, fever, chills, fatigue, headaches, radioactivity
As with any disease, the accurate diagnosis of Lymphoma is crucial to providing the best, most effective treatment for each individual patient. So while new medications and treatment strategies get a lot of attention, advances in diagnostic technologies are also exciting and important. At the 42nd annual meeting of the American Society of Hematology in December, there was a lot of talk about something called a gene chip -- or DNA microarray analysis -- which has recently been used to diagnose Diffuse Large B-Cell Lymphoma. What is a gene chip and how does it work? How will it lead to more effective treatments? Our panel of experts will include Margaret Shipp, MD, who presented on this topic at the conference.
Keywords: lymphoma, non hodgkins lymphoma, nonhodgkins lymphoma, burkitts lymphoma, lymphoma symptoms, hodgkinslymphoma, mantle cell lymphoma, burkitt's lymphoma, lymphoma cancer, lymphoma types, nonhodgkin's lymphoma, lymphoma treatment, large cell lymphoma, nonhodgkin's lymphoma treatment, b cell lymphoma, indolent lymphoma, cutaneous lymphoma, leukemia and lymphoma
As a behavioral psychologist, Brian Stabler knew a lot about dealing with emotional stress. But nothing prepared him for the challenge of lymphoma. Tune in to hear how he overcame NHL and the important lessons he learned in the process.
Keywords: NHL,Survivor,lymphoma
Harnessing radiation to attack cancer cells is the hottest new therapy in lymphoma treatment. But doctors are still determining when is the best time to use radioimmunotherapy. Find out how this therapy fits into lymphoma treatment plans.
Keywords: Non-Hodkgin's lymphoma, NHL, lymphoma, low-grade, indolent, radioimmunotherapy, cancer, monoclonal antibodies, radioactive, chemotherapy, targeted therapy, CHOP, Cytoxan, adriamycin, vincristine, prednisone, chlorambucil, Rituxan, rituximab, Bexxar, Zevalin, ibritumomab, tositumomab, CAT scan, bone marrow, blood test, radiation
The newest strategy in the fight against cancer is harnessing the power of radiation by linking it to targeted drug therapy. Learn the precautions people must take and how these treatments are safely delivered to people with cancer.
Keywords: lymphoma, non-Hodgkin's lymhoma, gilda's club, B-cells, lymphocytes, radioimmunotherapy, antigen, Zevalin, ibritumomab, monoclonal antibody, MAB, Rituxan, Rituximab, radiation therapy, cancer therapy, targeted therapy, external beam radiation, radiation treatments, Bexxar, tositumomab
Targeted therapies—treatments that zero in on cancerous cells—are among the current treatments for fighting cancer. One type of targeted therapy, monoclonal antibodies, has made great progress in recent years. Find out how scientists developed these treatments and how they can offer new hope to people with cancer.
Keywords: Non Hodgkin's Lymphoma, Lymphoma, gilda's club, Zevalin, monoclonal antibodies, immune system, HAMA, chemotherapy, Rituxan, CHOP, radioimmunotherapy, CD20 antigen, targeted therapies, NHL, mouse antibodies, malignant cells, targeted therapy, rituximab, Herceptin, CamPath, chronic lymphocytic leukemia, human anti-mouse antibodies, Mab
Data shows show that combining Rituxan and chemotherapy can have good results for patients with NHL. But does that mean that all patients will benefit from this strategy? Does adding chemotherapy to Rituxan bring small gains at the price of increased discomfort? Join us as we discuss these and other questions with experts from the American Society of Hematology 2001 meeting.
Keywords: rituxan, rituximab, combination therapy, lymphoma, b-cell lymphoma, chop, chemotherapy, chemo, non hodgkins lymphoma, non-hodgkins lymphoma, nhl, treatment, drugs, combo therapy, ash, american society of hematology meeting, meeting results, new trials
The aim of radiation therapy is to defeat cancer cells. Radiation can be delivered from a beam located outside the body, or by targeted medications called radioimmunotherapy. The choice of therapies will depend on the characteristics and type of tumor. Learn the differences between the conventional type of radiation and radioimmunotherapy.
Keywords: Non-Hodgkins Lymphoma, NHL, radiation therapy, radiation, antibodies, radioimmunotherapy, external beam radiation, conventional beam radiation, tumor, radioactive particles, antibody-targeted therapy, Zevalin, yytrium-90, Bexxar, I131, Rituxan, rituximab, ibritumomab, tositumomab, myelosuppression
Almost a quarter of all non-Hodgkin's lymphoma is classfied as follicular lymphoma. However, there are various options for treatment and choosing the best one may depend on the spcific details of your disease, your lifestyle and other symptoms you want to keep under control.
Keywords: non-hodgkin's lymphoma, follicular lymphoma, monoclonal antibodies, radioimmunotherapies, stem cell transplant
Non-Hodgkin's lymphoma is a cancer of the immune system. First-line treatment options include radiation therapy, chemotherapy, immunotherapy, radioimmunotherapy and stem cell transplant. How do you figure out which is right for you?
Keywords: non-Hodgkin's lymphoma, lymphoma, lymphoma treatment, non hodgkins, immunotherapy, monoclonal antibody therapy, cancer, chemotherapy, radiation
» Next page: Prognosis of Hodgkin's Disease
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
